EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Computational Docking as a Tool in Guiding the Drug Design of Rutaecarpine Derivatives as Potential SARS-CoV-2 Inhibitors

Shengying Lin iD, Xiaoyang Wang iD, Roy Wai-Lun Tang, Ran Duan, Ka Wing Leung iD, Tina Ting-Xia Dong, Sarah E Webb iD, Andrew L Miller, Karl Wah-Keung Tsim

Molecules · 2024

DOI: 10.3390/molecules29112636 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Shengying Lin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Chinese Medicine, Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China. Hauptthemen laut MEDLINE: Indole Alkaloids, SARS-CoV-2, Molecular Docking Simulation, Quinazolines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health and Medical Research Fund, Hong Kong Government Food and Health Bureau, Zhongshan Municipal Bureau of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

COVID-19 continues to spread around the world. This is mainly because new variants of the SARS-CoV-2 virus emerge due to genomic mutations, evade the immune system and result in the effectiveness of current therapeutics being reduced. We previously established a series of detection platforms, comprising computational docking analysis, S-protein-based ELISA, pseudovirus entry, and 3CL protease activity assays, which allow us to screen a large library of phytochemicals from natural products and to determine their potential in blocking the entry of SARS-CoV-2. In this new screen, rutaecarpine (an alkaloid from Evodia rutaecarpa) was identified as exhibiting anti-SARS-CoV-2 activity. Therefore, we conducted multiple rounds of structure-activity-relationship (SAR) studies around this phytochemical and generated several rutaecarpine analogs that were subjected to in vitro evaluations. Among these derivatives, RU-75 and RU-184 displayed remarkable inhibitory activity when tested in the 3CL protease assay, S-protein-based ELISA, and pseudovirus entry assay (for both wild-type and omicron variants), and they attenuated the inflammatory response induced by SARS-CoV-2. Interestingly, RU-75 and RU-184 both appeared to be more potent than rutaecarpine itself, and this suggests that they might be considered as lead candidates for future pharmacological elaboration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Indole AlkaloidsSARS-CoV-2Molecular Docking SimulationQuinazolinesAntiviral AgentsDrug DesignHumansStructure-Activity RelationshipCOVID-19 Drug TreatmentCoronavirus 3C ProteasesVirus InternalizationQuinazolinones

Stichwörter der Autor:innen

SARS-CoV-2computational dockingdrug designrutaecarpinestructure-activity-relationship studyviral entry

Substanzen

rutecarpineIndole AlkaloidsQuinazolinesAntiviral AgentsCoronavirus 3C ProteasesQuinazolinones

Autor:innen und Institutionen

  • Center for Chinese Medicine, Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China.
  • State Key Laboratory of Molecular Neuroscience, Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China.

ORCID-Profile: Shengying Lin, Xiaoyang Wang, Ka Wing Leung, Sarah E Webb

Förderung

  • Health and Medical Research Fund
  • Hong Kong Government Food and Health Bureau
  • Zhongshan Municipal Bureau of Science and Technology
  • Hong Kong Innovation Technology Fund (ITCPD/17-9)
  • Shenzhen Science and Technology Innovation Committee
  • Hong Kong RGC Theme-Based Research Scheme
  • Key-Area Research and Development Program of Guangdong Province
  • GBA Institute of Collaborate Innovation

Zitieren

APA

Lin, S., Wang, X., Tang, R. W., Duan, R., Leung, K. W., Dong, T. T., Webb, S. E., Miller, A. L., & Tsim, K. W. (2024). Computational Docking as a Tool in Guiding the Drug Design of Rutaecarpine Derivatives as Potential SARS-CoV-2 Inhibitors. Molecules. https://doi.org/10.3390/molecules29112636

Vancouver

Lin S, Wang X, Tang RW, Duan R, Leung KW, Dong TT, et al. Computational Docking as a Tool in Guiding the Drug Design of Rutaecarpine Derivatives as Potential SARS-CoV-2 Inhibitors. Molecules. 2024. doi:10.3390/molecules29112636

BibTeX
@article{Lin2024,
  author = {Lin, Shengying and Wang, Xiaoyang and Tang, Roy Wai-Lun and Duan, Ran and Leung, Ka Wing and Dong, Tina Ting-Xia and Webb, Sarah E and Miller, Andrew L and Tsim, Karl Wah-Keung},
  title = {Computational Docking as a Tool in Guiding the Drug Design of Rutaecarpine Derivatives as Potential SARS-CoV-2 Inhibitors},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29112636}
}
Kostenlos starten →